Medical laboratory company Sonic Healthcare has emphasised its role in backing the fight against coronavirus after delivering more than one million COVID-19 jabs.
The Australian vaccinations were given through government-run hubs and its network of more than 200 medical centres across the country.
Sonic, one of Australia's largest diagnostic companies, also conducted tens of thousands of COVID-19 tests and other related services.
Its base business is general laboratory services, pathology and radiology services.
For the first four months of the 2021/22 financial year, Sonic reported underlying earnings before interest, tax, depreciation and amortisation of $991 million, up 16 per cent.
Revenue rose five per cent to just over $3 billion, Sonic said on Thursday, on the back of "substantial volumes" of COVID-19 tests.
Despite the good results, Sonic said it was too early to provide earnings guidance for the full year.
"The pandemic continues to cause fluctuations in both COVID-19 testing revenues and to a lesser extent the base business," Sonic said.
Sonic is holding its annual general meeting for shareholders on Thursday.
Chairman Mark Compton told the meeting that 2020/21 was an outstanding year for the company.
"Sonic and its amazing people answered the call to battle the COVID-19 pandemic by working with governments and other organisations in myriad ways," Professor Compton said.
Its strong performance allowed it to pay down more than $1 billion in debt, leaving Sonic in its best gearing position in 20 years.
Sonic shares closed on Wednesday at $38.58 each.
